Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityNo recent work listed

Jianhong Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0194-1334; OpenAlex author ID A5100662563. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. SPRR3 Contributes to Aggressiveness of Pancreatic Cancer Cells via NF-κB Signaling Pathway. Last author DOI 10.1155/2023/7518744↗
  2. Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated VEGF signaling pathway. First author DOI 10.3892/or.2013.2529↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuankang Xie · 1 shared paper, 2023 · strength 0.20
  2. Hongfei Tong · 1 shared paper, 2013 · strength 0.03
  3. Sheng‐Zhang Lin · 1 shared paper, 2013 · strength 0.03
  4. Heqi Bu · 1 shared paper, 2013 · strength 0.03
  5. Hui Chen · 1 shared paper, 2013 · strength 0.03
  6. Zhaohong Wang · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.